Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Gastrointestinal Therapeutics market report explains the definition, types, applications, major countries, and major players of the Gastrointestinal Therapeutics market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
GlaxoSmithKline
Johnson & Johnson
Shire Pharmaceuticals
Allergan
Eli Lilly
Pfizer
AstraZeneca
AbbVie
Takeda
Merck
Procter & Gamble
F Hoffmann-La Roche
Tillotts Pharma
Amgen
Novartis
By Type:
Oral
Parenteral
By End-User:
IBD
Irritable Bowel Syndrome (IBS)
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Gastrointestinal Therapeutics Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Gastrointestinal Therapeutics Outlook to 2028- Original Forecasts
-
2.2 Gastrointestinal Therapeutics Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Gastrointestinal Therapeutics Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Gastrointestinal Therapeutics Market- Recent Developments
-
6.1 Gastrointestinal Therapeutics Market News and Developments
-
6.2 Gastrointestinal Therapeutics Market Deals Landscape
7 Gastrointestinal Therapeutics Raw Materials and Cost Structure Analysis
-
7.1 Gastrointestinal Therapeutics Key Raw Materials
-
7.2 Gastrointestinal Therapeutics Price Trend of Key Raw Materials
-
7.3 Gastrointestinal Therapeutics Key Suppliers of Raw Materials
-
7.4 Gastrointestinal Therapeutics Market Concentration Rate of Raw Materials
-
7.5 Gastrointestinal Therapeutics Cost Structure Analysis
-
7.5.1 Gastrointestinal Therapeutics Raw Materials Analysis
-
7.5.2 Gastrointestinal Therapeutics Labor Cost Analysis
-
7.5.3 Gastrointestinal Therapeutics Manufacturing Expenses Analysis
8 Global Gastrointestinal Therapeutics Import and Export Analysis (Top 10 Countries)
-
8.1 Global Gastrointestinal Therapeutics Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Gastrointestinal Therapeutics Export by Region (Top 10 Countries) (2017-2028)
9 Global Gastrointestinal Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Gastrointestinal Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Parenteral Consumption and Growth Rate (2017-2022)
-
9.2 Global Gastrointestinal Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global IBD Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Irritable Bowel Syndrome (IBS) Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Gastrointestinal Therapeutics Market Analysis and Outlook till 2022
-
10.1 Global Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.2.2 Canada Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.2.3 Mexico Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.3.2 UK Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.3.3 Spain Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.3.4 Belgium Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.3.5 France Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.3.6 Italy Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.3.7 Denmark Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.3.8 Finland Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.3.9 Norway Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.3.10 Sweden Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.3.11 Poland Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.3.12 Russia Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.3.13 Turkey Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.4.2 Japan Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.4.3 India Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.4.4 South Korea Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.4.5 Pakistan Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.4.6 Bangladesh Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.4.7 Indonesia Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.4.8 Thailand Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.4.9 Singapore Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.4.10 Malaysia Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.4.11 Philippines Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.4.12 Vietnam Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.5.2 Colombia Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.5.3 Chile Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.5.4 Argentina Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.5.5 Venezuela Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.5.6 Peru Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.5.7 Puerto Rico Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.5.8 Ecuador Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.6.2 Kuwait Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.6.3 Oman Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.6.4 Qatar Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.6.5 Saudi Arabia Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.6.6 United Arab Emirates Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.7.2 South Africa Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.7.3 Egypt Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.7.4 Algeria Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Gastrointestinal Therapeutics Consumption (2017-2022)
-
10.8.2 New Zealand Gastrointestinal Therapeutics Consumption (2017-2022)
11 Global Gastrointestinal Therapeutics Competitive Analysis
-
11.1 GlaxoSmithKline
-
11.1.1 GlaxoSmithKline Company Details
-
11.1.2 GlaxoSmithKline Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 GlaxoSmithKline Gastrointestinal Therapeutics Main Business and Markets Served
-
11.1.4 GlaxoSmithKline Gastrointestinal Therapeutics Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Johnson & Johnson
-
11.2.1 Johnson & Johnson Company Details
-
11.2.2 Johnson & Johnson Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Johnson & Johnson Gastrointestinal Therapeutics Main Business and Markets Served
-
11.2.4 Johnson & Johnson Gastrointestinal Therapeutics Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Shire Pharmaceuticals
-
11.3.1 Shire Pharmaceuticals Company Details
-
11.3.2 Shire Pharmaceuticals Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Shire Pharmaceuticals Gastrointestinal Therapeutics Main Business and Markets Served
-
11.3.4 Shire Pharmaceuticals Gastrointestinal Therapeutics Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Allergan
-
11.4.1 Allergan Company Details
-
11.4.2 Allergan Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Allergan Gastrointestinal Therapeutics Main Business and Markets Served
-
11.4.4 Allergan Gastrointestinal Therapeutics Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Eli Lilly
-
11.5.1 Eli Lilly Company Details
-
11.5.2 Eli Lilly Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Eli Lilly Gastrointestinal Therapeutics Main Business and Markets Served
-
11.5.4 Eli Lilly Gastrointestinal Therapeutics Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Pfizer
-
11.6.1 Pfizer Company Details
-
11.6.2 Pfizer Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Pfizer Gastrointestinal Therapeutics Main Business and Markets Served
-
11.6.4 Pfizer Gastrointestinal Therapeutics Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 AstraZeneca
-
11.7.1 AstraZeneca Company Details
-
11.7.2 AstraZeneca Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 AstraZeneca Gastrointestinal Therapeutics Main Business and Markets Served
-
11.7.4 AstraZeneca Gastrointestinal Therapeutics Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 AbbVie
-
11.8.1 AbbVie Company Details
-
11.8.2 AbbVie Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 AbbVie Gastrointestinal Therapeutics Main Business and Markets Served
-
11.8.4 AbbVie Gastrointestinal Therapeutics Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Takeda
-
11.9.1 Takeda Company Details
-
11.9.2 Takeda Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Takeda Gastrointestinal Therapeutics Main Business and Markets Served
-
11.9.4 Takeda Gastrointestinal Therapeutics Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Merck
-
11.10.1 Merck Company Details
-
11.10.2 Merck Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Merck Gastrointestinal Therapeutics Main Business and Markets Served
-
11.10.4 Merck Gastrointestinal Therapeutics Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Procter & Gamble
-
11.11.1 Procter & Gamble Company Details
-
11.11.2 Procter & Gamble Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Procter & Gamble Gastrointestinal Therapeutics Main Business and Markets Served
-
11.11.4 Procter & Gamble Gastrointestinal Therapeutics Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 F Hoffmann-La Roche
-
11.12.1 F Hoffmann-La Roche Company Details
-
11.12.2 F Hoffmann-La Roche Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 F Hoffmann-La Roche Gastrointestinal Therapeutics Main Business and Markets Served
-
11.12.4 F Hoffmann-La Roche Gastrointestinal Therapeutics Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Tillotts Pharma
-
11.13.1 Tillotts Pharma Company Details
-
11.13.2 Tillotts Pharma Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Tillotts Pharma Gastrointestinal Therapeutics Main Business and Markets Served
-
11.13.4 Tillotts Pharma Gastrointestinal Therapeutics Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Amgen
-
11.14.1 Amgen Company Details
-
11.14.2 Amgen Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Amgen Gastrointestinal Therapeutics Main Business and Markets Served
-
11.14.4 Amgen Gastrointestinal Therapeutics Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Novartis
-
11.15.1 Novartis Company Details
-
11.15.2 Novartis Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Novartis Gastrointestinal Therapeutics Main Business and Markets Served
-
11.15.4 Novartis Gastrointestinal Therapeutics Product Portfolio
-
11.15.5 Recent Research and Development Strategies
12 Global Gastrointestinal Therapeutics Market Outlook by Types and Applications to 2028
-
12.1 Global Gastrointestinal Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Parenteral Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Gastrointestinal Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global IBD Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Irritable Bowel Syndrome (IBS) Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Gastrointestinal Therapeutics Market Analysis and Outlook to 2028
-
13.1 Global Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.2.2 Canada Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.2.3 Mexico Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.3.2 UK Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.3.3 Spain Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.3.4 Belgium Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.3.5 France Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.3.6 Italy Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.3.7 Denmark Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.3.8 Finland Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.3.9 Norway Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.3.10 Sweden Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.3.11 Poland Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.3.12 Russia Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.3.13 Turkey Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.4.2 Japan Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.4.3 India Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.4.4 South Korea Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.4.8 Thailand Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.4.9 Singapore Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.4.11 Philippines Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.5.2 Colombia Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.5.3 Chile Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.5.4 Argentina Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.5.6 Peru Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.6.3 Oman Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.6.4 Qatar Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.7.2 South Africa Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.7.3 Egypt Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.7.4 Algeria Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Gastrointestinal Therapeutics Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Gastrointestinal Therapeutics
-
Figure of Gastrointestinal Therapeutics Picture
-
Table Global Gastrointestinal Therapeutics Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Gastrointestinal Therapeutics Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Parenteral Consumption and Growth Rate (2017-2022)
-
Figure Global IBD Consumption and Growth Rate (2017-2022)
-
Figure Global Irritable Bowel Syndrome (IBS) Consumption and Growth Rate (2017-2022)
-
Figure Global Gastrointestinal Therapeutics Consumption by Country (2017-2022)
-
Table North America Gastrointestinal Therapeutics Consumption by Country (2017-2022)
-
Figure United States Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Canada Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Mexico Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Gastrointestinal Therapeutics Consumption by Country (2017-2022)
-
Figure Germany Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure UK Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Spain Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Belgium Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure France Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Italy Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Denmark Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Finland Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Norway Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Sweden Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Poland Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Russia Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Turkey Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Table APAC Gastrointestinal Therapeutics Consumption by Country (2017-2022)
-
Figure China Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Thailand Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Singapore Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Philippines Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Table South America Gastrointestinal Therapeutics Consumption by Country (2017-2022)
-
Figure Brazil Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Colombia Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Chile Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Argentina Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Peru Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Table GCC Gastrointestinal Therapeutics Consumption by Country (2017-2022)
-
Figure Bahrain Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Oman Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Qatar Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Africa Gastrointestinal Therapeutics Consumption by Country (2017-2022)
-
Figure Nigeria Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Africa Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Egypt Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Algeria Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Oceania Gastrointestinal Therapeutics Consumption by Country (2017-2022)
-
Figure Australia Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Gastrointestinal Therapeutics Consumption and Growth Rate (2017-2022)
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Gastrointestinal Therapeutics Main Business and Markets Served
-
Table GlaxoSmithKline Gastrointestinal Therapeutics Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Gastrointestinal Therapeutics Main Business and Markets Served
-
Table Johnson & Johnson Gastrointestinal Therapeutics Product Portfolio
-
Table Shire Pharmaceuticals Company Details
-
Table Shire Pharmaceuticals Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Pharmaceuticals Gastrointestinal Therapeutics Main Business and Markets Served
-
Table Shire Pharmaceuticals Gastrointestinal Therapeutics Product Portfolio
-
Table Allergan Company Details
-
Table Allergan Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Gastrointestinal Therapeutics Main Business and Markets Served
-
Table Allergan Gastrointestinal Therapeutics Product Portfolio
-
Table Eli Lilly Company Details
-
Table Eli Lilly Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Gastrointestinal Therapeutics Main Business and Markets Served
-
Table Eli Lilly Gastrointestinal Therapeutics Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Gastrointestinal Therapeutics Main Business and Markets Served
-
Table Pfizer Gastrointestinal Therapeutics Product Portfolio
-
Table AstraZeneca Company Details
-
Table AstraZeneca Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Gastrointestinal Therapeutics Main Business and Markets Served
-
Table AstraZeneca Gastrointestinal Therapeutics Product Portfolio
-
Table AbbVie Company Details
-
Table AbbVie Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Gastrointestinal Therapeutics Main Business and Markets Served
-
Table AbbVie Gastrointestinal Therapeutics Product Portfolio
-
Table Takeda Company Details
-
Table Takeda Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Gastrointestinal Therapeutics Main Business and Markets Served
-
Table Takeda Gastrointestinal Therapeutics Product Portfolio
-
Table Merck Company Details
-
Table Merck Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Gastrointestinal Therapeutics Main Business and Markets Served
-
Table Merck Gastrointestinal Therapeutics Product Portfolio
-
Table Procter & Gamble Company Details
-
Table Procter & Gamble Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Procter & Gamble Gastrointestinal Therapeutics Main Business and Markets Served
-
Table Procter & Gamble Gastrointestinal Therapeutics Product Portfolio
-
Table F Hoffmann-La Roche Company Details
-
Table F Hoffmann-La Roche Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Gastrointestinal Therapeutics Main Business and Markets Served
-
Table F Hoffmann-La Roche Gastrointestinal Therapeutics Product Portfolio
-
Table Tillotts Pharma Company Details
-
Table Tillotts Pharma Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tillotts Pharma Gastrointestinal Therapeutics Main Business and Markets Served
-
Table Tillotts Pharma Gastrointestinal Therapeutics Product Portfolio
-
Table Amgen Company Details
-
Table Amgen Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Gastrointestinal Therapeutics Main Business and Markets Served
-
Table Amgen Gastrointestinal Therapeutics Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Gastrointestinal Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Gastrointestinal Therapeutics Main Business and Markets Served
-
Table Novartis Gastrointestinal Therapeutics Product Portfolio
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Parenteral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global IBD Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Irritable Bowel Syndrome (IBS) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastrointestinal Therapeutics Consumption Forecast by Country (2022-2028)
-
Table North America Gastrointestinal Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gastrointestinal Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Germany Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Gastrointestinal Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure China Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Gastrointestinal Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Brazil Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Gastrointestinal Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Gastrointestinal Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Gastrointestinal Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure Australia Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Gastrointestinal Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
